Latest stories
-
Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk 42% in Late-Stage Trial
Discover how custom mRNA cancer vaccines train the immune system against tumor neoantigens to prevent melanoma recurrence compared to standard adjuvant therapy.
-
Understanding How Novel Drug Targets Aim to Slow Alzheimer’s
Explore how emerging mid-stage research into blood-brain barriers and tau proteins shapes the future of Alzheimer’s disease drug development.
-
Sugary Drinks Linked to Higher Teen Anxiety and Depression Risk in Australian Study
A three‑year study of 6,500 Australian adolescents shows daily sugary‑drink intake increases the odds of meeting screening thresholds for depression and anxiety,…
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
Non-invasive blood tests are moving beyond niche use to become vital tools for tracking treatment response, detecting recurrence, and screening for cancer.
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
The 2026 AACR Cancer Progress Report highlights a rise in survival rates and the emergence of innovative drug classes like PROTACs and…
-
MD Anderson Reports Phase 3 Lung Cancer Immunotherapy Result and Other New Studies
New clinical findings from MD Anderson highlight advanced immunotherapy and targeted treatments, offering renewed hope for lung and prostate cancer patients.
-
New Studies Show Immunotherapy Gaining Ground in Lung, Prostate and Childhood Cancers
Researchers are moving beyond traditional toxic treatments by engineering the immune system to recognize and destroy cancer cells with greater precision.
-
Viatris Secures FDA Approval for RYZUMVI to Treat Presbyopia in Adults
Viatris wins FDA approval for RYZUMVI to treat presbyopia, adding a new option for aging eyes while seeking a U.S. commercial partner.
-
Genentech’s AL050 Deal Validates Blood-Brain Barrier Strategy
A $1.17 billion licensing agreement with Alector signals Genentech’s strategic pivot toward specialized neuro-autoimmune and rare disease biologics.
-
How a Hidden Fat-Sensing Protein Could Unlock Immunotherapy for Deadly Colorectal Cancers
A new study reveals how tweaking a single molecular switch in immune cells could turn ‘untreatable’ tumors into immunotherapy responders—without headlines.
-
How USC Scientists Are Solving the Supply Bottleneck in CAR-T Cancer Therapy
New research into lab-grown cells aims to overcome the scarcity and complexity of current CAR-T treatments, potentially expanding access for cancer patients.
-
How H. pylori’s Silent Spread Fuels 760,000 Cancers a Year—and Why Most Go Untreated
A Nobel-winning discovery linked stomach bacteria to cancer, yet antibiotic resistance and screening gaps leave millions at risk—especially in low-income nations.
-
Thyroid Eye Disease Affects 16 in 100,000 Women Yearly, Smoking Multiplies Risk
Thyroid eye disease, linked to Graves’ disease, occurs in 16 per 100,000 women annually, with smoking increasing risk nearly eightfold and severe…
-
Google AMIE Study Shows AI Helps Doctors Prepare for Patient Visits
A large-scale study found AI chatbot summaries aided physician preparation in 75% of cases and matched final diagnoses 90% of the time.
-
NIH Funds Study On Power Outage Mortality Risks
Researchers to investigate how power outages affect survival rates for patients relying on devices like ventilators or dialysis machines
-
FDA Approves Zanvastro, the First Drug for the Rare Brain Disorder Alexander Disease
Madison, October 16 — The US Food and Drug Administration has approved Zanvastro, the first drug designed to directly treat Alexander disease,…
-
NCCN Adds Anktiva Plus BCG for Papillary-Only, BCG-Unresponsive Bladder Cancer
Silver Spring, October 16 — On October 14, 2026, the U.S. Food and Drug Administration approved an expanded use of nogapendekin alfa…
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
Neurologists and epilepsy specialists from across the region gather in Kuala Lumpur from 19 to 22 November 2026 for the 16th Asian…
-
Blue Cross Blue Shield Association Ties Hospital AI Coding Tools to $942 Million in Added Costs
BERKELEY, September 27 — Artificial intelligence tools used in medical billing and claims processing pushed patient costs up by nearly $1 billion…
-
US Patients Caught Between Hospitals and Insurers in Price Talks
WASHINGTON, September 25 — In the United States, most people with private health insurance rely on a system in which hospital prices…
-
Semaglutide’s Heart Benefits May Go Beyond Weight Loss, Study Finds
Washington, September 24 — A new analysis of clinical trial data suggests that the reduced risk of heart disease seen in people…
-
Blood Test Detects 17 Cancers With 99.64% Specificity
LONDON, September 23 — A large prospective study has found that a multicancer blood test detected cancer signals across 17 broad cancer…
-
French Study Links Food Preservatives to Higher Hypertension Risk
Paris, September 22 — A large French study published in 2024 in the journal Hypertension found that people who consumed the most…
-
ALS Patient Improves, Still Works as Physician After RNA Therapy
BETHESDA, September 19 — A man with a rare, inherited form of amyotrophic lateral sclerosis has become the first person to receive…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992